Listed
2019-04
First close
CHF 50.00
split-adjusted
Since listing
+25%
104 points—
Current
CHF 62.28
$35.4 B · 2026-11-20 17:30 CET
Peak
CHF 63.32
$36 B2026-11
Low
CHF 62.28
$35.4 B2026-11
Latest change
-1.6%
Prior close → 17:30
Change since first
-1.6%
2026-11
52-week range
CHF 47.80 – CHF 68.34
Drawdown
-8.9%
Avg vol 3m
1.1M
Dividend yield
0.45%
Price history
Last session · Nov 20Nov 20, 2026
Monthly closes from Yahoo Finance, split-adjusted, dividends excluded. Earlier points are actual closes, not reconstructed.
Time (CET)CloseMarket capChange
- 17:30CHF 62.28$35.4 B-1.6%
- 17:25CHF 62.38$35.5 B-1.5%
- 17:20CHF 62.38$35.5 B-1.5%
- 17:15CHF 62.46$35.5 B-1.4%
- 17:10CHF 62.48$35.6 B-1.3%
- 17:05CHF 62.56$35.6 B-1.2%
- 17:00CHF 62.52$35.6 B-1.3%
- 16:55CHF 62.62$35.6 B-1.1%
- 16:50CHF 62.54$35.6 B-1.2%
- 16:45CHF 62.56$35.6 B-1.2%
- 16:40CHF 62.38$35.5 B-1.5%
- 16:35CHF 62.58$35.6 B-1.2%
- 16:30CHF 62.74$35.7 B-0.9%
- 16:25CHF 62.76$35.7 B-0.9%
- 16:20CHF 62.54$35.6 B-1.2%
- 16:15CHF 62.56$35.6 B-1.2%
- 16:10CHF 62.66$35.7 B-1.0%
- 16:05CHF 62.82$35.8 B-0.8%
- 16:00CHF 62.66$35.7 B-1.0%
- 15:55CHF 62.70$35.7 B-1.0%
Ownership & Control
Shareholding as of 2026-11-19- Controlling entity
- Publicly traded Swiss corporation with a broad institutional shareholder base and no controlling shareholder.
- Insiders
- 0.19%
- Institutions
- 66.17%(1,176 holders)
- Free float
- 99.74%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →- Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth2026-11-10
- Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 22026-10-20
- FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes2026-10-16
